The present invention relates to a compound which can be used in the treatment of infections with pathogenic bacteria, in particular pathogens mediating pathogenicity by quinolone dependent production of virulence factors, such as e.g. Pseudomonas aeruginosa and species of the genus Burkholderia, and which can be used for treating bacterial or chronic infections or can be used in combination with other anti-bacterial agents, such as antibiotics, to increase sensitivity of the bacteria for treatment of e.g. multiresistant strains in e.g. mammals.
本发明涉及一种可用于治疗与致病细菌感染有关的化合物,特别是通过
喹诺酮依赖性产生毒力因子介导致病原性的病原体,例如
铜绿假单胞菌和伯克霍尔德菌属的物种,并可用于治疗细菌或慢性感染,或可与其他抗菌药物(如抗生素)联合使用,以增加细菌对治疗的敏感性,例如用于治疗哺乳动物中的多重耐药菌株。